Spirometric abnormalities in patients with fabry disease and effect of substitutive therapy

J. D. Aubert, U. Widmer, T. Brack, B. Vogt, F. Barbey (Lausanne, Zurich, Bern, Switzerland)

Source: Annual Congress 2004 - Pulmonary and respiratory pump function
Session: Pulmonary and respiratory pump function
Session type: Thematic Poster Session
Number: 461
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. D. Aubert, U. Widmer, T. Brack, B. Vogt, F. Barbey (Lausanne, Zurich, Bern, Switzerland). Spirometric abnormalities in patients with fabry disease and effect of substitutive therapy. Eur Respir J 2004; 24: Suppl. 48, 461

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reversibility of diffusion capacity abnormalities in patients with clinical hypothyroidism with establishment of euthyroid state
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 626s
Year: 2006

Compliance with nebulized therapy in patients with chronic lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001

Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Immediate effect of osteopathic manual therapy on hyperinflation in patients with severe chronic obstructive pulmonary disease.
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017


The effect of oral corticosteroids on spirometric parameters in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004

Severe fibrotic lung disease – How much therapy is too much therapy?
Source: Annual Congress 2008 - Clinical Grand Round - an interactive session
Year: 2008


Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension
Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018
Year: 2018



Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: management
Year: 2010


Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 821-822
Year: 2014


Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 819-821
Year: 2014


The clinico-immunological evaluation of the ribomunyl therapy in complex treatment of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

The effect preoperative intervention with long-acting bronchodilator for untreated patients with obstructive lung disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Myopathy and polyneuropathy in patients with COPD: evaluation of frequency and effects on outcome of pulmonary rehabilitation
Source: Eur Respir J 2006; 28: Suppl. 50, 69s
Year: 2006

Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Echocardiographic abnormalities in patients with COPD entering pulmonary rehabilitation
Source: Annual Congress 2013 –The best abstracts in pulmonary rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2013


Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

Electrocardiographic and echocardiographic abnormalities in COPD patients according to disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011